Prenatal Clinical Samples Enable Development of QC Reference
Materials for Prenatal and Preimplantation Genetic Testing

Advancing prenatal testing requires an adequate supply of reference materials with clinical and genetic diversity. Using patient remnant samples for assay controls is not a viable or scalable option. 

Development and performance of a formalin-damaged multiplexed DNA tumor mutation FFPE reference material

Redevelopment of assays and routine testing for trisomies and microdeletions requires highly characterized reference materials to ensure the quality of testing.

Download this poster to learn more about this clinical description of a cohort study, the development of reference materials suitable for prenatal and preimplantation testing, as well as the characterization and clinical performance of the newly developed reference materials.

 

Complete this form for your free download:

We’re committed to your privacy. SeraCare will not share or sell your data. View our privacy policy below for details.